Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target
Open Access
- 5 April 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1388999
Abstract
Heat shock protein 70 (HSP70) is a highly conserved protein functioning as a “molecular chaperone”, which is integral to protein folding and maturation. In addition to its high expression within cells upon stressful challenges, HSP70 can be translocated to the cell membrane or released from cells in free form or within extracellular vesicles (EVs). Such trafficking of HSP70 is also present in cancer cells, as HSP70 is overexpressed in various types of patient samples across a range of common malignancies, signifying that extracellular HSP70 (eHSP70) can serve as a tumor biomarker. eHSP70 is involved in a broad range of cancer-related events, including cell proliferation and apoptosis, extracellular matrix (ECM) remodeling, epithelial-mesenchymal transition (EMT), angiogenesis, and immune response. eHSP70 can also induce cancer cell resistance to various treatments, such as chemotherapy, radiotherapy, and anti-programmed death-1 (PD-1) immunotherapy. Though the role of eHSP70 in tumors is contradictory, characterized by both pro-tumor and anti-tumor effects, eHSP70 serves as a promising target in cancer treatment. In this review, we comprehensively summarized the current knowledge about the role of eHSP70 in cancer progression and treatment resistance and discussed the feasibility of eHSP70 as a cancer biomarker and therapeutic target.Keywords
This publication has 216 references indexed in Scilit:
- Exogenous heat shock proteins HSPA1A and HSPB1 regulate TNF‐α, IL‐1β and IL‐10 secretion from monocytic cellsFEBS Open Bio, 2023
- Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancerInternational Journal of Cancer, 2017
- FasL and the NKG2D receptor are required for the secretion of the Tag7/PGRP‐S–Hsp70 complex by the cytotoxic CD8+ lymphocytesIUBMB Life, 2016
- GRP78 Mediates Cell Growth and Invasiveness in Endometrial CancerJournal of Cellular Physiology, 2014
- Involvement of CD91 and scavenger receptors in Hsp70‐facilitated activation of human antigen‐specific CD4+ memory T cellsEuropean Journal of Immunology, 2010
- Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78International Journal of Cancer, 2010
- Patient survival by Hsp70 membrane phenotypeCancer, 2007
- HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD‐1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanomaInternational Journal of Cancer, 2006
- The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cellsEuropean Journal of Immunology, 2005
- Endotoxin-free heat-shock protein 70 fails to induce APC activationEuropean Journal of Immunology, 2002